Printer Friendly

New Study: Global Female Contraceptives Market 2015-2019.

[ClickPress, Fri Oct 09 2015]

Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy. Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus. Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods.

Full Report Details at

-

http://www.fastmr.com/prod/1055991_global_female_contraceptives.aspx?afid=301

Technavio's analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.

This report covers the following types of female contraceptive:

Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)

Drugs (Birth control pills and Emergency pills)

Technavio's report, Global Female Contraceptive Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

Americas

APAC

EMEA

Key vendors

Allergan

Merck

Pfizer

Teva Pharmaceutical

Other prominent vendors

Ansell

Church & Dwight

Bayer

Agile Therapeutics

Caya

Fuji Latex

Janssen Pharmaceuticals

HLL Lifecare

Lipocine

Mayer Laboratories

Okamoto Industries

Reckitt Benckiser Group

Today Sponge

Female Health

Key market driver

Improved family planning

For a full, detailed list, view our report

Key market challenge

Lack of social acceptance

For a full, detailed list, view our report

Key market trend

Increased unplanned pregnancy

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

Copyright [c] 2015 ClickPress Provided by SyndiGate Media Inc. ( Syndigate.info ).
COPYRIGHT 2015 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:ClickPress
Date:Oct 9, 2015
Words:473
Previous Article:Market Report, "Beer in Ireland", published.
Next Article:Germ Cell Tumors - Pipeline Review, H2 2015 - New Report Available.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters